Literature DB >> 3304993

Epileptogenesis and the immature brain.

S L Moshé.   

Abstract

Epidemiological studies indicate that the incidence of seizures is highest early in life. This report discusses the experimental data derived from studies of focal epileptogenesis of the immature brain in tandem with ongoing maturational changes. During development, neurons have characteristic neurophysiological properties. Local interictal discharges are long in duration, lack a stereotypic morphology, and have limited fields. Yet the immature brain is very susceptible to the development of bilateral, although asynchronous, seizures and status epilepticus induced by amygdala kindling or by convulsant drugs. This increased seizure susceptibility may be due to a functional immaturity of a substantia nigra, GABA-sensitive output system. The morbidity of convulsions occurring early in life may not be as grave as previously thought in terms of subsequent acquisition of "normal" developmental milestones. The propensity to develop recurrent convulsions in adulthood is not related to the severity of a single seizure in infancy. Although multiple severe seizures may predispose animals to the development of seizures later in life, this is not a unique feature of the immature brain, since it also occurs in the adult brain. Finally, there is evidence that the immature brain may respond to anticonvulsant drugs differently from its mature counterpart; these findings emphasize the need to develop new antiepileptic therapies that take into account the maturational state of the brain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304993     DOI: 10.1111/j.1528-1157.1987.tb05753.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

Review 1.  Diffusion in brain extracellular space.

Authors:  Eva Syková; Charles Nicholson
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 2.  Do seizures damage the brain? The epidemiological evidence.

Authors:  C M Verity
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

3.  Post-traumatic early epilepsy in pediatric age group with emphasis on influential factors.

Authors:  Ozkan Ateş; Sevim Ondül; Cağatay Onal; Mehmet Büyükkiraz; Hakan Somay; Süleyman R Cayli; Mehmet A Göğüsgeren; Metin Orakdöğen; Ayhan Koçak; Saim Yoloğlu; Zafer Berkman; Mahir Tevrüz
Journal:  Childs Nerv Syst       Date:  2005-05-12       Impact factor: 1.475

4.  Posttraumatic seizures in children with severe traumatic brain injury.

Authors:  Jorge I Arango; Christopher P Deibert; Danielle Brown; Michael Bell; Igor Dvorchik; P David Adelson
Journal:  Childs Nerv Syst       Date:  2012-07-28       Impact factor: 1.475

Review 5.  Generation of Febrile Seizures and Subsequent Epileptogenesis.

Authors:  Bo Feng; Zhong Chen
Journal:  Neurosci Bull       Date:  2016-08-25       Impact factor: 5.203

6.  Low risk of seizure recurrence after early withdrawal of antiepileptic treatment in the neonatal period.

Authors:  L Hellström-Westas; G Blennow; M Lindroth; I Rosén; N W Svenningsen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

7.  Propofol and Sevoflurane Anesthesia in Early Childhood Do Not Influence Seizure Threshold in Adult Rats.

Authors:  Paweł Piwowarczyk; Elżbieta Rypulak; Justyna Sysiak-Sławecka; Dorota Nieoczym; Katarzyna Socała; Aleksandra Wlaź; Piotr Wlaź; Waldemar Turski; Mirosław Czuczwar; Michał Borys
Journal:  Int J Environ Res Public Health       Date:  2021-11-24       Impact factor: 3.390

8.  GABA(A) receptors in normal development and seizures: friends or foes?

Authors:  Aristea S Galanopoulou
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

9.  Short-Term Effects of Phenobarbitone on Electrographic Seizures in Neonates.

Authors:  Evonne Low; Nathan J Stevenson; Sean R Mathieson; Vicki Livingstone; Anthony C Ryan; Janet M Rennie; Geraldine B Boylan
Journal:  Neonatology       Date:  2016-03-31       Impact factor: 4.035

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.